News
Endo Announces Q1 2024 Financial Results for Endo International plc
MALVERN, Pa., May 15, 2024 /PRNewswire/ — Endo, Inc. (“Endo” or the “Company”), a newly formed entity that recently acquired substantially all of the assets of Endo International plc (“EIP”) as contemplated by EIP’s reorganization plan, will announce selected first quarter 2024 financial results for Endo International plc on May 30, 2024, and members of Endo’s senior management team will hold a conference call on May 31, 2024 at 8:30 a.m. ET for registered holders of its debt and equity securities.
(PRNewsfoto/Endo International plc)
There are three ways to join the call:
Please attend 10 minutes before the scheduled start time.
About Endo
Endo is a diversified specialty pharmaceutical company that boldly turns insights into life-improving therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best lives. Find out more at www.endo.com or connect with us at LinkedIn.
Spin-off
View original content to download multimedia:https://www.prnewswire.com/news-releases/endo-to-announce-first-quarter-2024-financial-results-for-endo-international-plc-302146793.html
SOURCE Endo, Inc.
Spin-off
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2024/15/c8972.html